
DeepLook Medical: Advanced medical software for radiomic data extraction and breast cancer research.
DeepLook Medical, founded with a mission to revolutionize medical imaging, focuses on developing advanced software for radiomic data extraction and breast cancer research. Their core product, DL Precise™, is a multimodal deep analytics imaging tool designed to enhance image interpretation for radiologists. By leveraging shape-recognition technology, DeepLook Medical aims to provide accurate, efficient, and personalized care throughout the treatment pathway, particularly addressing the challenges of detecting cancers in dense breast tissues.
Notable figures associated with DeepLook Medical include leading radiologists and data scientists who contribute to its innovative approach. The company has garnered attention from investors interested in advancing medical technology and improving cancer diagnostics. Key achievements include the development of a comprehensive phenotype database for mammography, which is currently available for research purposes. DeepLook Medical's impact lies in its potential to significantly improve diagnostic accuracy and treatment outcomes for breast cancer patients.

DeepRadiology
deepradiology.com

Nulogix Health
deephealth.com

DeepSight Technology
deepsightinc.com

Enlitic
enlitic.com

ChestAi

Retrieve Medical

DeepTek
deeptek.ai

MedCognetics
medcognetics.com

Clearview Diagnostics

Dyad Medical
dyadmed.com

Decision Sciences Medical

Latest Medical

Medical Search Technologies

Delphinus Medical Technologies
delphinusmt.com

Deepcell
Companies similar to DeepLook Medical include DeepRadiology, Nulogix Health, DeepSight Technology and Enlitic.
DeepLook Medical was founded in 2018.
DeepLook Medical's headquarters is located in New Haven, CT, US.
DeepLook Medical's most recent funding round was for $1.5M (USD) in January 2023.
As of Jan 18, 2023, DeepLook Medical has raised a total of $1.5M (USD).
DeepLook Medical has 7 employees as of Feb 4, 2024.